Pharmacists in Silverdale, Washington


44 Pharmacists found in Silverdale
female pharmacist

Dr. Rachel Butler


Pharmacist
3201 Nw Randall Way, Silverdale, WA 98383
360-536-6010     360-536-9100

female pharmacist

Sahrah Yesmyne Sant


Pharmacist
3201 Nw Randall Way, Silverdale, WA 98383
360-692-3966    

female pharmacist

Sara Elizabeth Mcintyre, PHARMD


Pharmacist
9709 Silverdale Way Nw, Silverdale, WA 98383
360-620-9662     360-692-7571



female pharmacist

Sara Herring, PHARMD


Pharmacist
3201 Nw Randall Way, Silverdale, WA 98383
360-536-6010     360-536-9100

female pharmacist

Sarah Schiavone, PHARM. D


Pharmacist - Oncology
Silverdale Medical Center, 10452 Silverdale Way Nw, Silverdale, WA 98383
253-680-8826    

female pharmacist

Mrs. Stacy Lee Peretzman, RPH


Pharmacist
9709 Silverdale Way Nw, Silverdale, WA 98383
360-692-7536    

female pharmacist

Stephanie Stanton, PHARMD


Pharmacist
2860 Nw Bucklin Hill Rd, Silverdale, WA 98383
360-692-3410    

female pharmacist

Mrs. Theresa Carol Lambert, RPH CDE


Pharmacist
10452 Silverdale Way Nw, Silverdale, WA 98383
360-307-7365     360-307-7325

male pharmacist

Thomas Joseph Kazikiewicz


Pharmacist
9709 Silverdale Way Nw, Silverdale, WA 98383
360-692-7536     360-962-7571

male pharmacist

Tyler James Lincoln, PHARM. D.


Pharmacist
9709 Silverdale Way Nw, Silverdale, WA 98383
360-692-7536    

male pharmacist

Mr. Wayne Tim Luk, RPH


Pharmacist
3201 Nw Randall Way, Silverdale, WA 98383
360-536-6010     360-536-9100

male pharmacist

Mr. Yoichiro Shuin


Pharmacist
9709 Silverdale Way Nw, Silverdale, WA 98383
360-692-7536    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.